Access cutting-edge crohn's disease treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.
Access crohn's disease specialists in Chicago at no cost
This study follows strict safety protocols and ethical guidelines
All study-related crohn's disease treatment provided free
This is a randomised, double-blind, parallel group, placebo-controlled Phase IIa study designed to evaluate the efficacy and safety of AZD7798 in participants with moderate to severe Crohn's disease.
Sponsor: AstraZeneca
Check if you qualify for this crohn's disease clinical trial in Chicago, IL
If you're searching for crohn's disease treatment options in Chicago, IL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced crohn's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.